Emerging Company Profile Introgen: Clinic first, infrastructure later

Introgen Therapeutics Inc. has built its business model on the core tenet of "virtual" thinkers: get as far as possible on someone else's nickel and don't spend money on your own infrastructure until you think you've got something worth building around.

The Austin, Texas, gene therapy company was founded in 1993 based on 15 years of research by Jack Roth, now at the University of Texas M.D. Anderson Cancer Center, going back to his years at the National Cancer Institute. The company has six Phase I/II trials in progress with 140 patients, with five more trials slated to begin in the next few months, yet it remained a virtual company until six months ago.